ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 369327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 369327; 2) Community: the network communities that were significantly associated with the response to NSC 369327; 3) Molecule: the relationships between components within communities and NSC 369327; 4) MDR: the compounds that were significantly associated with the NSC 369327.

NSC Compound Enrichment Correlation
NSC 711175 Null 0.0176693828663435 0.17896142
NSC 711806 Null 0.0176693828663435 0.026176921
NSC 720147 Null 0.0176693828663435 0.18347795
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.0176693828663435 0.28603707
NSC 757306 Pyrimethamine (USAN) 0.0176693828663435 0.10647828
NSC 763635 N-(benzo[d]thiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide 0.0176693828663435 0.28584203
NSC 109451 Null 0.0176693828663438 0.048875
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0176693828663438 0.042910543
NSC 12097 Resorufine 0.0176693828663438 0.1570794
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0176693828663438 0.2693464
Total:106  Current:44    [First] [Prev] [Next] [Last]